safety of retatrutide ⚠️ “RETA” is NOT an approved weight-loss medication. Social media is full “RETA” offers—but here's what you should know. is a promising investigational medicine developed by Eli Lilly. The Phase What is Retatrutide? Is it

A provider makes the final call

Chromatin immunoprecipitation HEK293T cells transfected with pEGFP, pEGFP-ELT-3, or pEGFP-PQM-1, with tig-2p::luciferase were subjected to chromatin immunoprecipitation (ChIP) 48 h post-transfection, as reported (He et al, 2021

- Doctorando en Odontologa por la Universidad del Pas Vasco/ Euskal Herriko Unibersitatea

Pardali E, Sanchez-Duffhues G, Gomez-Puerto M, Ten Dijke P

How quickly will I see results

With new information about metabolic benefits separate from weight loss, this will definitely need to be reconsidered. She estimates that about 5% to 8% of patients in her practice are what she calls weight non-responders to GLP-1s